| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |